Minimizing Fertility-sparing Treatment for Low Volume Early Stage Cervical Cancer; Is Less the (R)Evolution?


Journal

Anticancer research
ISSN: 1791-7530
Titre abrégé: Anticancer Res
Pays: Greece
ID NLM: 8102988

Informations de publication

Date de publication:
Jul 2020
Historique:
received: 27 05 2020
revised: 16 06 2020
accepted: 19 06 2020
entrez: 5 7 2020
pubmed: 6 7 2020
medline: 14 7 2020
Statut: ppublish

Résumé

The aim of this study was to conduct a review on less radical fertility-sparing surgical treatment for early-stage cervical cancer. We conducted a Medline search from 2014 to 2018 regarding less radical fertility-sparing techniques, such as simple trachelectomy or cervical conization, with pelvic lymphadenectomy. We also assessed the impact of the removal of the parametrium on the obstetric and oncologic outcome, in women who desire to preserve their fertility. We analyzed studies about cervical conization and simple trachelectomy, together with pelvic lymphadenectomy in early-stage cervical cancer. We also assessed the importance of parametrial involvement in reducing morbidity, without jeopardizing the oncologic outcome of these patients. Studies demonstrate that in tumors ≤2 cm, without lymphovascular Space Invasion and without evidence of parametrial involvement, a less radical fertility-sparing surgical approach could increase pregnancy rates and have a positive effect on the quality of life of these patients. Standard fertility-sparing treatment for early-stage cervical cancer is still radical trachelectomy with pelvic lymphadenectomy. However, studies suggest that the omission of parametrectomy is a feasible and safe option. Simple trachelectomy or cervical conization, both combined with pelvic lymphadenectomy are acceptable approaches in a selected group of patients with early-stage cervical cancer.

Sections du résumé

BACKGROUND/AIM OBJECTIVE
The aim of this study was to conduct a review on less radical fertility-sparing surgical treatment for early-stage cervical cancer.
MATERIALS AND METHODS METHODS
We conducted a Medline search from 2014 to 2018 regarding less radical fertility-sparing techniques, such as simple trachelectomy or cervical conization, with pelvic lymphadenectomy. We also assessed the impact of the removal of the parametrium on the obstetric and oncologic outcome, in women who desire to preserve their fertility.
RESULTS RESULTS
We analyzed studies about cervical conization and simple trachelectomy, together with pelvic lymphadenectomy in early-stage cervical cancer. We also assessed the importance of parametrial involvement in reducing morbidity, without jeopardizing the oncologic outcome of these patients. Studies demonstrate that in tumors ≤2 cm, without lymphovascular Space Invasion and without evidence of parametrial involvement, a less radical fertility-sparing surgical approach could increase pregnancy rates and have a positive effect on the quality of life of these patients.
CONCLUSION CONCLUSIONS
Standard fertility-sparing treatment for early-stage cervical cancer is still radical trachelectomy with pelvic lymphadenectomy. However, studies suggest that the omission of parametrectomy is a feasible and safe option. Simple trachelectomy or cervical conization, both combined with pelvic lymphadenectomy are acceptable approaches in a selected group of patients with early-stage cervical cancer.

Identifiants

pubmed: 32620604
pii: 40/7/3651
doi: 10.21873/anticanres.14354
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

3651-3658

Informations de copyright

Copyright© 2020, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Auteurs

Charalampos Theofanakis (C)

Unit of Gynecologic Oncology, 1 Department of Obstetrics & Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece ch.theofanakis@gmail.com.

Dimitrios Haidopoulos (D)

Unit of Gynecologic Oncology, 1 Department of Obstetrics & Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Nikolaos Thomakos (N)

Unit of Gynecologic Oncology, 1 Department of Obstetrics & Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Alexandros Rodolakis (A)

Unit of Gynecologic Oncology, 1 Department of Obstetrics & Gynecology, Alexandra Hospital, National and Kapodistrian University of Athens, Athens, Greece.

Christina Fotopoulou (C)

Imperial College Healthcare NHS Trust, Hammersmith Hospital, London, U.K.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH